09:15 HUA HAN BIO-PHARMACEUTICAL HOLDINGS LIMITED<00587> - Ann (2) permission to deal in, the Shares on the Stock Exchange, as well as compliance with the stock admission requirements of HKSCC, the Shares will be accepted as eligible securities by HKSCC for deposit, clearance and settlement in the Central Clearing and Settlement System (`CCASS') with effect from the commencement date of dealings in the Shares on the Stock Exchange or such other date as determined by HKSCC. All activities under CCASS are subject to the General Rules of CCASS and CCASS Operational Procedures in effect from time to time. The offer of 142,000,000 Shares (the `Offer Shares') comprises an offer (the `Public Offer') of initially 14,200,000 Shares (the `Public Offer Shares') to the public in Hong Kong and a placing (the `Placing') of initially 127,800,000 Shares (the `Placing Shares') (comprising 85,200,000 New Shares and 42,600,000 Sale Shares) to professional, institutional and private investors in Hong Kong (the Public Offer and the Placing, collectively referred to herein as the `Share Offer'). If you are a full time employee in Hong Kong of the Company or its subsidiaries (excluding the directors, the chief executive of the Company, existing beneficial owners of the Shares and their respective associates) (the `Eligible Employees') and want your application to be given preferential consideration, you should complete and sign the PINK application form. Up to 1,420,000 Public Offer Shares (representing 10% of the Public Offer Shares initially available for subscription) are available for subscription by the Eligible Employees. Applications for the Placing Shares and the Public Offer Shares will only be considered on the basis of the terms and conditions of the Prospectus and, in respect of the Public Offer Shares, also on the basis of the terms and conditions of the WHITE, YELLOW and PINK application forms. Applicants under the Public Offer who would like to be allotted Public Offer Shares in their own names should complete and sign the WHITE application forms. Applicants under the Public Offer who would like to be allotted Public Offer Shares issued in the name of HKSCC Nominees Limited and deposited directly into CCASS for the credit of their CCASS investor participant stock accounts or the stock accounts of their designated CCASS participants maintained in CCASS should complete and sign the YELLOW application forms. Multiple or suspected multiple applications on WHITE and YELLOW application forms, applications made by an applicant for more than 100% of the Public Offer Shares being initially available for public subscription (excluding the Public Offer Shares initially available to Eligible Employees on a preferential basis) and an application made by one applicant on one PINK form for more than 100% of the Public Offer Shares initially available for application by Eligible Employees, being 1,420,000 Shares (other than the Directors, chief executive of the Company and its subsidiaries, existing beneficial owners of the Shares and their respective associates (as defined in the Listing Rules) on a preferential basis under the Public Offer will be rejected and only one application on a WHITE and YELLOW application form may be made for the benefit of any person. Applicants for the Public Offer Shares are required to undertake and confirm that they have not taken up any Placing Shares under the Placing. The Offer Price will be not more than HK$0.87 and is expected to be not less than HK$0.74. The Offer Price is expected to be fixed by agreement between the Lead Manager (on behalf of the Underwriters) and the Company on the Price Determination Date. The Price Determination Date is expected to be on Wednesday, 4th December, 2002 and, in any event not later than 10:00 a.m. on Thursday, 5th December, 2002. The Company and the Lead Manager (on behalf of the Underwriters) may agree to reduce the indicative Offer Price range below that stated in the Prospectus at any time prior to the morning of the last day for lodging WHITE and YELLOW application forms under the Public Offer. In the event of a reduction in the indicative Offer Price range, the Company will issue an announcement to be published in The Standard (in English) and Hong Kong Economic Times (in Chinese) not later than the morning of the last day for lodging WHITE and YELLOW application forms under the Public Offer. If applications for the Offer Shares have been submitted prior to the latest time for lodging WHITE and YELLOW application forms under the Public Offer, then even if the indicative Offer Price range is so reduced, such applications cannot be subsequently withdrawn. If, in any event, the Lead Manager (on behalf of the Underwriters) and the Company are unable to reach an agreement on the Offer Price at or before 10:00 a.m. on Thursday, 5th December, 2002, the Share Offer will not become unconditional and will lapse. The Share Offer is conditional on the conditions as stated in the paragraph headed `Conditions of the Share Offer' under the section headed `Structure of the Share Offer' in the Prospectus. If the Share Offer does not become unconditional on or before 27th December, 2002, all application monies received from applicants under the Share Offer will be refunded, without interest, on the terms set out under the paragraph headed `Refund of your money' in the application forms. Applicants who have applied for 1,000,000 Public Offer Shares or more and have indicated in their application forms that they wish to